J. Goldman & Co LP - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 106 filers reported holding ATHIRA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q1 2022$1,552,000
+10.1%
114,950
+6.2%
0.07%
-9.0%
Q4 2021$1,410,000108,2000.08%
Other shareholders
ATHIRA PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Logos Global Management LP 1,630,744$21,249,0002.19%
VR Adviser, LLC 1,000,000$13,030,0001.78%
ACUTA CAPITAL PARTNERS, LLC 310,030$4,040,0001.70%
Ikarian Capital, LLC 860,000$11,207,0001.67%
Bristlecone Advisors, LLC 761,563$9,923,0001.19%
Perceptive Advisors 6,851,832$89,280,0000.69%
DAFNA Capital Management LLC 160,983$2,098,0000.53%
PATHSTONE FAMILY OFFICE, LLC 1,442,247$18,792,0000.47%
Potomac Capital Management, Inc. 40,000$521,0000.46%
RTW INVESTMENTS, LP 1,906,557$24,842,0000.36%
View complete list of ATHIRA PHARMA INC shareholders